Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Trends China Coal Mine Blast in Shanxi Kills at Least 82 Worst Disaster in 16 Years Intuitive Surgical Shares Slide to 52Week Low Amid Market Headwinds Indian Markets Potential LowPriced Stocks Under 100 Highlighted for This Week GitHubs AI Coding Ambitions Face Outage Setbacks as Competition Intensifies Barnes Noble CEO James Daunt Clarifies Booksellers Position on AIGenerated Books A Straightforward Rejection BDCI Q1 2026 Earnings Positive EPS of 005 Reported Despite Absence of Revenue Details AREC Q4 2025 Earnings Massive EPS Surprise of 1008 Beats Estimates NewtekOne Inc 850 Fixed Rate Senior Notes due 2029 NEWTG Q1 2026 Earnings EPS Slightly Misses Estimates Revenue Not Disclosed DMRC Q1 2026 Earnings EPS Surprises to the Upside Driving Positive Stock Reaction IRM Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response FULTP Q1 2026 Earnings Preferred Dividend Beat Supports Stable Income Profile Telephone and Data Systems TDS Drops 46 as Selling Pressure Intensifies Anixa Biosciences ANIX Holds Steady at 273 as Consolidation Continues San Juan Basin Royalty Trust SJT Edges Higher as Energy Sector Consolidates Cabaletta Bio CABA Climbs 27 as Biotech Stock Tests Key Resistance Near 414 Rocket Pharmaceuticals Warrant RCKTW Slides 12 as Price Nears Penny Stock Territory Global Leaders Monitor Potential TrumpXi Summit Amid Trade Uncertainty ISBA Q1 2026 Earnings Earnings Per Share Falls Well Short of Expectations Actinium Pharmaceuticals ATNM Modest Gain Above Support as Biotech Stock Holds Key Level Hewlett Packard Enterprise HPE Edges Higher as Shares Test Key Resistance Masonglory Limited MSGY Holds Steady Near Support as Trading Range Tightens mF International Limited MFI Slips Over 10 as Selling Pressure Intensifies Lululemon LULU Holds Steady Near Support as Market Eyes Key Resistance Levels Exzeo Group Inc XZO Rallies 386 as Buyers Defend Key Support at 1280 Phoenix Asia Holdings PHOE Drops 582 Key Levels and Potential Scenarios Liquidia Corporation LQDA Gains 32 as Biotech Momentum Builds Key Levels Ahead